Medical News

RSS

Creating the first genetically susceptible mice for late-onset Alzheimer's

Mice don't get Alzheimer's - and while that's good news for mice, it's a big problem for biomedical researchers seeking to understand the disease and test new treatments.

24 Jul 2024

Breakthrough research identifies fibrin as key factor in preterm brain bleeds

Mark Petersen, MD, has seen firsthand the devastating effects of brain bleeds in premature babies. It's an exceedingly common condition that affects up to 20 percent of infants born before 28 weeks of gestation, bringing an increased risk for developmental delays and autism.

24 Jul 2024

AI model enhances DCIS diagnosis using tissue image analysis

Ductal carcinoma in situ (DCIS) is a type of preinvasive tumor that sometimes progresses to a highly deadly form of breast cancer. It accounts for about 25 percent of all breast cancer diagnoses.

24 Jul 2024

Kaempferol's promise in fighting triple-negative breast cancer

Review highlights kaempferol's potential in treating triple-negative breast cancer through various anticancer mechanisms and improving chemotherapeutic efficacy.

24 Jul 2024

Lifestyle and socioeconomic status affect health impacts of ultra-processed foods

A recent study found that lifestyle and socioeconomic factors influence the negative impact of ultra-processed foods (UPF) on health-related quality of life (HRQoL). Higher UPF intake is linked to poorer physical health, especially among women, smokers, and those with low socioeconomic status.

24 Jul 2024

Proteomic signatures enhance risk prediction for both common and rare diseases

Researchers have developed sparse prediction models combining plasma proteins and clinical data to predict the 10-year risk of 218 diseases. The study, involving over 41,000 participants, highlights the enhanced predictive power of proteomic signatures.

24 Jul 2024

WVU researchers explore immune cell interactions in multiple sclerosis

A West Virginia University immunologist is exploring how the interaction between two types of immune cells within the central nervous system covering causes multiple sclerosis to develop.

24 Jul 2024

Personalized text messages effectively promote increased physical activity after cardiovascular events

Exercise is one of the best ways to reduce your risk of heart disease or having a second cardiovascular event, such as a heart attack or stroke.

24 Jul 2024

$ActiveHip+ enhances recovery for elderly hip fracture patients$

ActiveHip+ enhances recovery for elderly hip fracture patients

This digital solution was developed as part of a European project led by the University of Granada (UGR) and the Andalusian Health Service (SAS).

24 Jul 2024

LGBTIQ+ and cisgender heterosexual individuals exhibit more stress hormones during controversial campaign

How did the 2021 national marriage equality referendum campaign in Switzerland affect the well-being of the LGBTIQ+ community?

24 Jul 2024

Unveiling nature’s hunters: Dr. Skylar Johnson's research on carnivorous pitcher plants with Absorbance 96 & One in Borneo's rainforests

In this interview, Dr. Skylar Johnson shares her thrilling adventures and groundbreaking research on carnivorous Nepenthes pitcher plants in the lush rainforests of Borneo.

From Byonoy 24 Jul 2024

Study reveals skin bacteria's role in chronic bone infections after joint surgery

In individuals who have undergone knee or hip replacement surgery, clinicians are noticing increasing numbers of chronic bone infections linked to a bacterial strain commonly found on the skin.

24 Jul 2024

Chronic and new anxiety tied to increased dementia risk

In a study published in the Journal of the American Geriatrics Society, both chronic and new anxiety were associated with an increased risk of dementia. However, where anxiety had resolved, there was no association with dementia risk.

24 Jul 2024

Comprehensive dataset from A4 study yields key insights about Alzheimer's disease

Data from the Anti-Amyloid Treatment in Asymptomatic Alzheimer's (A4) study, the first and largest clinical trial of pre-symptomatic Alzheimer's disease, is now widely available to researchers studying the condition.

24 Jul 2024

Challenging antibiotic resistance with dual-action macrolones

A new antibiotic that works by disrupting two different cellular targets would make it 100 million times more difficult for bacteria to evolve resistance, according to new research from the University of Illinois Chicago.

24 Jul 2024

World-famous wall drug isn’t immune from challenges facing rural pharmacies

Stacey Schulz parks in a rear lot to avoid the crowded Main Street entrances to her local pharmacy.

24 Jul 2024

Louisiana reclassifies drugs used in abortions as controlled dangerous substances

Louisiana lawmakers have added two drugs commonly used in pregnancy and reproductive health care to the state's list of controlled dangerous substances, a move that has alarmed doctors in the state.

24 Jul 2024

Broken String Biosciences appoints Steve Becker as Chief Commercial Officer

Broken String Biosciences (“Broken String”), a genomics company driving development of the next generation of more precise, safe, and effective cell and gene therapies, today announced it has appointed Steve Becker as Chief Commercial Officer.

24 Jul 2024

Metrion Biosciences appoints Dr Chris Mathes as Chief Commercial Officer

Metrion Biosciences Ltd (“Metrion”), the specialist preclinical contract research organization (CRO) and a leader in ion channel screening, today announced the appointment of Dr Chris Mathes, MBA, as Chief Commercial Officer (CCO). Chris will work alongside the Company’s expert leadership team to drive commercial strategy and lead global business development and marketing activities.

24 Jul 2024

Enterprise Therapeutics doses first person with cystic fibrosis in Phase 2 trial for novel therapy ETD001

Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of those suffering from respiratory disease, today announced dosing of the first person with cystic fibrosis (pwCF) in its Phase 2a trial of ETD001.

24 Jul 2024

Medical News

Creating the first genetically susceptible mice for late-onset Alzheimer's

Breakthrough research identifies fibrin as key factor in preterm brain bleeds

AI model enhances DCIS diagnosis using tissue image analysis

Kaempferol's promise in fighting triple-negative breast cancer

Lifestyle and socioeconomic status affect health impacts of ultra-processed foods

Proteomic signatures enhance risk prediction for both common and rare diseases

WVU researchers explore immune cell interactions in multiple sclerosis

Personalized text messages effectively promote increased physical activity after cardiovascular events

ActiveHip+ enhances recovery for elderly hip fracture patients

LGBTIQ+ and cisgender heterosexual individuals exhibit more stress hormones during controversial campaign

Unveiling nature’s hunters: Dr. Skylar Johnson's research on carnivorous pitcher plants with Absorbance 96 & One in Borneo's rainforests

Study reveals skin bacteria's role in chronic bone infections after joint surgery

Chronic and new anxiety tied to increased dementia risk

Comprehensive dataset from A4 study yields key insights about Alzheimer's disease

Challenging antibiotic resistance with dual-action macrolones

World-famous wall drug isn’t immune from challenges facing rural pharmacies

Louisiana reclassifies drugs used in abortions as controlled dangerous substances

Broken String Biosciences appoints Steve Becker as Chief Commercial Officer

Metrion Biosciences appoints Dr Chris Mathes as Chief Commercial Officer

Enterprise Therapeutics doses first person with cystic fibrosis in Phase 2 trial for novel therapy ETD001

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News